175 related articles for article (PubMed ID: 31595482)
1. Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis.
Dos Santos G; Shende V; Damaso S; Yeakey A
Adv Ther; 2019 Dec; 36(12):3340-3355. PubMed ID: 31595482
[TBL] [Abstract][Full Text] [Related]
2. Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
Dos Santos G; Nguyen BY; Damaso S; Godderis L; Martínez-Gómez X; Eckermann T; Loos H; Salamanca de la Cueva I; Shende V; Schmidt AC; Yeakey A
Drug Saf; 2020 Mar; 43(3):265-279. PubMed ID: 31884676
[TBL] [Abstract][Full Text] [Related]
3. Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
Salamanca de la Cueva I; Cinconze E; Eckermann T; Nwoji U; Godderis L; Lu E; Martínez-Gómez X; Wang H; Yanni E
Drug Saf; 2021 Dec; 44(12):1375-1390. PubMed ID: 34694589
[TBL] [Abstract][Full Text] [Related]
4. Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season.
Dos Santos G; Wang H; Jindal P; Rybo M; Roul H; Pallem S; Eckermann T; Godderis L; Martínez Gómez X; Godard E; Soler M; Yousefi M; Salamanca de la Cueva I; Nwoji U
Infect Dis Ther; 2022 Feb; 11(1):463-483. PubMed ID: 34961900
[TBL] [Abstract][Full Text] [Related]
5. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older.
Dos Santos G; Devadiga R; Kim CS; Bang J
Drug Saf; 2024 Apr; 47(4):365-375. PubMed ID: 38483767
[TBL] [Abstract][Full Text] [Related]
6. Passive enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season.
Dos Santos G; Yeakey A; Shende V; Smith K; Lin F; Zandman-van-Dijk E; Damaso S; Schmidt A
BMJ Open; 2019 Aug; 9(8):e028043. PubMed ID: 31427321
[TBL] [Abstract][Full Text] [Related]
7. Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring.
Dos Santos G; Eckermann T; Martínez-Gómez X; Parra J; Nwoji U; Salamanca de la Cueva I
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13098. PubMed ID: 36991538
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season.
de la Cueva IS; Gerber JE; Hastie A; Brotons C; Panzer F; Pirçon JY; Talsma P; Eckermann T; Nikic V; Gomez XM; Alsdurf H
Drug Saf; 2024 Jun; ():. PubMed ID: 38949714
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.
de Lusignan S; Dos Santos G; Byford R; Schuind A; Damaso S; Shende V; McGee C; Yonova I; Ferreira F
Adv Ther; 2018 Aug; 35(8):1199-1214. PubMed ID: 29995300
[TBL] [Abstract][Full Text] [Related]
10. Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season.
de Lusignan S; Damaso S; Ferreira F; Byford R; McGee C; Pathirannehelage S; Shende V; Yonova I; Schmidt A; Schuind A; Dos Santos G
Hum Vaccin Immunother; 2020 Aug; 16(8):1762-1771. PubMed ID: 32118513
[TBL] [Abstract][Full Text] [Related]
11. Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card.
de Lusignan S; Ferreira F; Damaso S; Byford R; Pathirannehelage S; Yeakey A; Yonova I; Schuind A; Dos Santos G
Hum Vaccin Immunother; 2019; 15(5):1048-1059. PubMed ID: 30648923
[TBL] [Abstract][Full Text] [Related]
12. Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season.
Chabanon AL; Wague S; Moureau A; Nissila M; Serradell L
BMC Public Health; 2021 Feb; 21(1):358. PubMed ID: 33588815
[TBL] [Abstract][Full Text] [Related]
13. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
Haber P; Moro PL; Ng C; Dores GM; Lewis P; Cano M
Vaccine; 2019 Mar; 37(11):1516-1520. PubMed ID: 30739795
[TBL] [Abstract][Full Text] [Related]
14. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
Haber P; Moro PL; Lewis P; Woo EJ; Jankosky C; Cano M
Vaccine; 2016 May; 34(22):2507-12. PubMed ID: 27015735
[TBL] [Abstract][Full Text] [Related]
15. Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21.
Syrkina O; Inamdar A; Wague S; Monfredo C; Nissilä M; Chabanon AL; Serradell L
BMC Public Health; 2022 Aug; 22(1):1506. PubMed ID: 35941631
[TBL] [Abstract][Full Text] [Related]
16. Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season.
Gandhi-Banga S; Chabanon AL; Eymin C; Caroe T; Butler K; Moureau A
Hum Vaccin Immunother; 2019; 15(9):2154-2158. PubMed ID: 30897026
[TBL] [Abstract][Full Text] [Related]
17. Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England.
de Lusignan S; Dos Santos G; Correa A; Haguinet F; Yonova I; Lair F; Byford R; Ferreira F; Stuttard K; Chan T
BMJ Open; 2017 May; 7(5):e015469. PubMed ID: 28515198
[TBL] [Abstract][Full Text] [Related]
18. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
[TBL] [Abstract][Full Text] [Related]
19. [Technical guidelines for seasonal influenza vaccination in China, 2019-2020].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1333-1349. PubMed ID: 31838802
[TBL] [Abstract][Full Text] [Related]
20. [Technical guidelines for seasonal influenza vaccination in China (2019-2020)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jan; 54(1):21-36. PubMed ID: 31914565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
